GLENDALE HEIGHTS, Ill. — Ampersand Capital Partners (“Ampersand”), a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors, announced today the acquisition of Biologos LLC (“Biologos”), a full-service manufacturer of custom and standard cell culture media, reagents, buffers, enzymes, and sera. The partnership with Ampersand will include investments to expand Biologos’ […]
Orpington, UK – Ampersand Capital Partners (“Ampersand”), a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors, announced today the acquisition of Specac Limited (“Specac”), an industry leader in the design and manufacture of spectroscopy accessories and sample prep solutions. “On behalf of the entire Specac organization, we are excited to […]
Sale of portfolio company, Specac International, to a US Private Equity investor is expected to deliver more than a 10x return The transaction generates approximate gross proceeds of £27 million to Foresight funds, including proceeds received to date Foresight invested in 2015 and helped position Specac as a global leader in mass spectroscopy accessories With […]
Binding Agreement to Acquire Substantially All NanoString Assets for $220 Million Pending Bankruptcy Court Approval Agreement Represents Major Step in Financial Restructuring and Provides Continuity for Customers and Employees SEATTLE — NanoString Technologies, Inc. (OTC: NSTGQ) (“NanoString” or the “Company”), a leading provider of life science tools for discovery and translational research, today announced that it has […]
BASEL, Switzerland — Bruker Corporation (Nasdaq: BRKR) is pleased to announce the successful closing of its acquisition of Chemspeed Technologies AG, a leading Swiss provider of automated laboratory R&D and QC workflow solutions. This acquisition, first announced in January 2024, marks another significant milestone in Bruker’s expansion in vendor-agnostic scientific software, R&D and QC digitalization, and […]
PROVIDENCE, R.I. — Next generation genomic tools company, Nabsys®, has executed a nonexclusive agreement with Canadian distributor, DMark Biosciences (“DMark”), for sales of its OhmX™ platform. OhmX is Nabsys’ first commercially available product and was released in October 2023. DMark will be responsible for distributing both the Nabsys OhmX™ Analyzer and consumables into both public and private research core […]
Indutrade has signed an agreement to acquire all shares in the Norwegian company Matriks AS, www.matriks.no, with annual sales of approximately NOK 215 million (SEK 205 million). Matriks is a technical trading company specialised on analysis instruments, systems and consumables for chemical and biochemical laboratories. The company offers a wide range of products within liquid- […]
BILLERICA, Massachusetts ─ Bruker today announced that it has completed the acquisition of Phasefocus Holdings Limited, which was already announced on December 22nd, 2023. Phasefocus is a privately held company that has leading expertise in imaging and image processing algorithms. Phasefocus has deployed their expertise to develop a novel optical microscope, called Livecyte, for label […]
Shimadzu Corporation acquired the catalytic microreactor business for gas chromatography (GC) from Activated Research Company, LLC (ARC, Minnesota, USA). In the Green Transformation (GX) area, many studies are in progress on the shift towards carbon-neutral (net zero greenhouse gas emissions) through new energy sources, such as hydrogen and biofuels, and on the capture and utilization […]
ELITechGroup is a differentiated, fast growing and profitable systems and assay provider for molecular diagnostics (MDx), biomedical systems/specialty IVD, and microbiology ELITechGroup offers the proprietary, fully automated sample-to-answer (S2A) molecular diagnostic (MDx) systems InGenius® and BeGenius® for mid-sized hospitals and esoteric testing Large and diversified ELITech MDx assay portfolio is focused on pathogens and viral […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
-
2023 Dividend Changes for Laboratory Tool Companies Reflect a Chink in the Armor
January 31, 2024 5:45 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
